NervGen Pharma Corp.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| NGEN | NGNE | VYGR | NBP | CRVO | ALEC | |
|---|---|---|---|---|---|---|
| Market cap | 145.16M | 551.91M | 115.23M | 117.16M | 23.59M | 254.58M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -4.0 | -4.8 | -1.5 | -0.8 | -1.1 | -3.1 |
| Price/book | 4.3 | 2.0 | 0.7 | 0.6 | 0.9 | -25.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −44.30% | −3.79% | −57.14% | −76.29% | −78.88% | +63.35% |
| Today | +2.27% | +3.41% | +2.19% | 0.00% | +0.65% | +11.22% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All NGEN news ›I Got Tired of Rewriting Audit Logs in Spring Boot — So I Built nerv-audit
Every backend system eventually hits this moment: “Who changed this record?” “What was the previous value?” “When did it happen?” Simple questions… until you actually need answers in production. In most of my Spring Boot projects, I relied…
NervGen Pharma (NASDAQ:NGEN) Stock Rating Raised to Sell at Wall Street Zen
Posted by Tristan Rich on Oct 25th, 2026 Wall Street Zen upgraded shares of NervGen Pharma (NASDAQ:NGEN – Free Report) from a strong sell rating to a sell rating in a research note released on Saturday,Wall Street Zen reports. Check Out…
NervGen (NASDAQ: NGEN) restates interim statements and nets C$77.9 million
Posted by Danessa Lincoln on Oct 17th, 2026 NervGen Pharma Corp. (NASDAQ: NGEN) said its audit committee found valuation errors in stock options and certain warrant derivative liabilities. The company restated its condensed consolidated…
Transcript : NervGen Pharma Corp. - Special Call
Presenter SpeechJames Valentine Good morning, and welcome to the externally led Patient-Focused Drug Development Meeting on Spinal cord injuries. I'm James Valentine. I'm here in the studio with Transcript : NervGen Pharma Corp. - Special…
Certain Warrants of NervGen Pharma Corp. are subject to a Lock-Up Agreement Ending on 21-JUL-2026.
These Warrants will be under lockup for 61 days starting from 21-MAY-2026 to... Certain Warrants of NervGen Pharma Corp are subject to a Lock-Up Agreement Ending on 21-JUL-2026 These Warrants will be
NervGen Pharma Corp.: Relative Strength Chart - Stock Nasdaq
Compare NervGen Pharma Corp. with the company of your choice via a Relative Strength chart. Real-time NGEN price, Nasdaq stock exchange Relative Strength Chart NervGen Pharma Corp. Biotechnology & Medical Research All financial news and…
NervGen Pharma Corp.: News in other languages | NGEN | CA64082X2032
NervGen Pharma Corp.: News, information and stories for NervGen Pharma Corp. | Nasdaq: NGEN | Nasdaq Other languages NervGen Pharma Corp. Biotechnology & Medical Research All financial news and data tailored to specific country editions
Leerink Partners Initiates Coverage on NervGen Pharma With Outperform Rating, $10 Price Target
... Biotechnology & Medical Research Leerink Partners Initiates Coverage on NervGen Pharma With Outperform Rating, $10 Price Target Published on 07/13/2026 at 07:38 am EDT
TD Cowen Initiates NervGen Pharma at Buy
NervGen Pharma has an average rating of buy and mean price target of $10.67, according to analysts polled by FactSet. ... Biotechnology & Medical Research TD Cowen Initiates NervGen Pharma at Buy Published on 06/11/2026 at 06:32 am EDT
NervGen Pharma Corp - Nvg-291 shows statistically significant gait quality improvement in phase 1b/2a connect sci study
NervGen Pharma Corp: NervGen Pharma Corp - Nvg-291 shows statistically significant gait quality improvement in phase 1b/2a connect sci study NervGen Pharma Corp - on track to initiate phase 3... Biotechnology & Medical Research NervGen…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com12
- themarketsdaily.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 14 articles, not a forecast.